Morris says advanced conversations are continuing with possible partners as they look to press ahead with the development of their flagship VAL401 lung cancer candidate.
ValiRx Plc enjoying strong industry interest in its cancer treatments
Quick facts: ValiRx PLC
Price: 20.5 GBX
Market Cap: £13.4 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE